Nagaileben Co., Ltd. AI Stock Analysis
Want to see JP:7447 full AI Analyst Report?
Nagaileben Co., Ltd. (7447) AI Stock Analysis
Nagaileben Co., Ltd.
(TSE/TYO:7447)
Nagaileben earns a moderate score driven primarily by its exceptionally low financial risk: no debt, a largely equity-funded balance sheet, and free cash flow that nearly matches reported earnings. Offsetting this are a soft growth and margin story — five years of flat revenue, roughly seven points of gross margin erosion, and a 27% decline in net income since 2021 — plus a modest 6.8% return on equity. Technicals are the weakest element, with the shares trading below all key moving averages and momentum indicators pointing lower. Valuation is mixed: a 19.3x P/E is not cheap given the earnings trajectory, but a well-covered 4.28% dividend yield and low beta provide defensive income support.
Nagaileben Co., Ltd. (7447) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 50.98B
- Dividend Yield
- 4.12%
- Average Volume (3M)
- 110.84K
- Price to Earnings (P/E)
- 19.2
- Beta (1Y)
- 0.53
- Revenue Growth
- 1.31%
- EPS Growth
- 6.19%
- Country
- Japan
- Employees
- 501
- Sector
- Consumer Cyclical
- Sector Strength
- 61
- Industry
- Apparel - Manufacturers
Nagaileben Co., Ltd. Business Overview & Revenue Model
Company Description
Nagaileben Co., Ltd. is a Japanese enterprise that manufactures and distributes apparel for the medical industry. Their product range includes specialized clothing for hospitals, clinics, and operating rooms. This company was established in 1915 and...
How the Company Makes Money
Nagaileben makes money mainly by selling uniforms and related apparel, with revenue recognized from product sales to business-to-business customers and distribution partners. Key revenue streams typically include (1) institutional and corporate sales...
Nagaileben Co., Ltd. Financial Statement Overview
Summary
A debt-free, fortress balance sheet (score 90) with roughly 93% equity funding and zero refinancing risk is the core strength, supported by healthy cash generation (score 74) — operating cash flow rebounded to ¥3.53bn and free cash flow to ¥3.31bn, equal to about 94% of net income. The drag is the income statement (score 64): revenue has been essentially flat for five years at ¥17.21bn, gross margin has compressed from 45.9% to 39.1%, and net income is down about 27% since 2021. Return on equity of 6.8% is modest for such a large, under-levered capital base, though the latest year shows early stabilization in margins and a return to top-line growth.
Income Statement
64PositiveBalance Sheet
90Very PositiveCash Flow
74Positive| Breakdown | TTM | Aug 2026 | Aug 2025 | Aug 2024 | Aug 2023 | Aug 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 17.21B | 17.21B | 16.98B | 16.41B | 17.18B | 17.75B |
| Gross Profit | 6.89B | 6.73B | 6.57B | 6.90B | 7.41B | 7.72B |
| EBITDA | 4.04B | 3.92B | 3.86B | 4.27B | 4.88B | 5.31B |
| Net Income | 2.65B | 2.65B | 2.57B | 2.82B | 3.23B | 3.78B |
Balance Sheet | ||||||
| Total Assets | 42.19B | 42.19B | 44.77B | 46.76B | 47.41B | 47.40B |
| Cash, Cash Equivalents and Short-Term Investments | 22.40B | 22.40B | 24.25B | 26.35B | 27.16B | 28.56B |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 3.14B | 3.14B | 3.45B | 4.06B | 4.19B | 5.14B |
| Stockholders Equity | 39.06B | 39.06B | 41.32B | 42.70B | 43.21B | 42.26B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 3.31B | 1.89B | 2.14B | 1.55B | 3.35B |
| Operating Cash Flow | 0 | 3.53B | 2.18B | 2.29B | 1.81B | 3.44B |
| Investing Cash Flow | 0 | 1.67B | 1.11B | -1.77B | 3.42B | -471.43M |
| Financing Cash Flow | 0 | -5.05B | -3.89B | -2.93B | -2.94B | -3.20B |
Nagaileben Co., Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7447, the sentiment is Positive. The current price of 1701.00 is above the 20-day moving average (MA) of 1690.90, above the 50-day MA of 1677.16, and above the 200-day MA of 1665.37, indicating a bullish trend. The MACD of 6.32 indicates Negative momentum. The RSI at 50.15 is Neutral, neither overbought nor oversold. The STOCH value of 49.42 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7447.
Nagaileben Co., Ltd. Peers Comparison
Overall Rating
JP:356975Outperform
JP:320172Outperform
JP:300267Neutral
JP:310466Neutral
JP:744764Neutral
JP:358062Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 75Outperform | JPY 191.54B | 12.68 | 9.85% | 2.27% | 16.78% | 5.60% | |
| 72Outperform | JPY 120.65B | 12.05 | ― | 2.44% | -0.33% | 40.20% | |
| 67Neutral | JPY 128.47B | 24.63 | 4.97% | 4.98% | -3.94% | 113.82% | |
| 66Neutral | JPY 94.04B | 14.37 | ― | 2.77% | 14.36% | 22.61% | |
| 64Neutral | JPY 50.95B | 19.24 | ― | 4.12% | 1.31% | 6.19% | |
| 62Neutral | JPY 24.86B | 9.64 | ― | 4.15% | 0.56% | 82.80% | |
| Sector * | 61Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |
* Consumer Cyclical Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:7447 | Nagaileben Co., Ltd. | 1701.00 | -115.72 | -6.37% | |
| JP:3002 | Gunze | 4335.00 | 525.75 | 13.80% | |
| JP:3569 | Seiren Co | 3570.00 | 494.01 | 16.06% | |
| JP:3104 | Fujibo Holdings, Inc. | 2782.00 | 529.55 | 23.51% | |
| JP:3201 | Japan Wool Textile Co., Ltd. | 1964.00 | 313.55 | 19.00% | |
| JP:3580 | KOMATSU MATERE Co., Ltd. | 650.00 | -151.52 | -18.90% |
Nagaileben Co., Ltd. Corporate Events
Nagaileben Launches ¥1 Billion Share Buyback to Bolster Shareholder Value
Nagaileben Co., Ltd., listed on the Tokyo Stock Exchange’s Prime Market, operates in the Japanese corporate sector with an emphasis on disciplined capital management and shareholder-focused policies. The company has consistently highlighted sharehold...
Nagaileben Posts Modest Profit Growth and Strong Balance Sheet, Signals Stable Outlook
Nagaileben Co., Ltd., a Tokyo-listed manufacturer of medical and professional apparel, reported modest growth for the fiscal year ended August 31, 2026, with net sales rising 1.3% to ¥17.2 billion and profit attributable to owners of the parent up 3....
Nagaileben Tightens Internal Control and Group Governance Framework
Nagaileben Co., Ltd. announced that its Board of Directors has approved a partial revision of its Basic Policy for Internal Control Systems, strengthening frameworks for legal compliance, risk management, and efficient decision-making. The updated po...
Nagaileben Nears Completion of ¥1 Billion Share Buyback Program
Nagaileben Co., Ltd. has completed a share repurchase program authorized by its board in late June, buying back 157,900 common shares between August 1 and August 12, 2026 via market purchases on the Tokyo Stock Exchange, at a total cost of approximat...
Nagaileben Advances Share Buyback, Repurchases Over 400,000 Shares
Nagaileben Co., Ltd. has been repurchasing its own common shares under a Board-approved program authorized on June 29, 2026, in accordance with provisions of the Companies Act. Between July 1 and July 31, 2026, the company acquired 360,400 shares thr...
Nagaileben Overhauls Governance With New Executive Officer System and Leaner Board
Nagaileben Co., Ltd. will introduce an Executive Officer system from September 1, 2026, aiming to respond more swiftly to changes in its business environment and to strengthen corporate governance. Under this framework, executive appointments and dis...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 02, 2026
